SNX5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.330800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.370400E-01
Normal-vs-Stage2
4.539400E-01
Normal-vs-Stage3
2.014000E-01
Normal-vs-Stage4
3.273800E-01
Stage1-vs-Stage2
6.231200E-01
Stage1-vs-Stage3
5.691800E-01
Stage1-vs-Stage4
9.044800E-01
Stage2-vs-Stage3
2.281800E-01
Stage2-vs-Stage4
8.073000E-01
Stage3-vs-Stage4
4.980800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.427600E-01
Normal-vs-AfricanAmerican
2.819200E-01
Normal-vs-Asian
3.331600E-01
Caucasian-vs-AfricanAmerican
9.052600E-01
Caucasian-vs-Asian
1.811970E-01
AfricanAmerican-vs-Asian
2.715000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.220200E-01
Normal-vs-Female
4.501400E-01
Male-vs-Female
5.626000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.780350E-01
Normal-vs-Age(41-60Yrs)
5.096400E-01
Normal-vs-Age(61-80Yrs)
4.015200E-01
Normal-vs-Age(81-100Yrs)
5.064800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.976080E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.443840E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.239500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.807900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.369600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.343800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.691000E-01
Normal-vs-Daily Drinker
3.701800E-01
Normal-vs-Weekly Drinker
3.028000E-01
Normal-vs-Occasional Drinker
5.319000E-01
Normal-vs-Social Drinker
4.245800E-01
Non Drinker-vs-Daily Drinker
9.938600E-01
Non Drinker-vs-Weekly Drinker
4.961400E-01
Non Drinker-vs-Occasional Drinker
5.538200E-02
Non Drinker-vs-Social Drinker
5.054200E-01
Daily Drinker-vs-Weekly Drinker
5.057600E-01
Daily Drinker-vs-Occasional Drinker
7.947600E-02
Daily Drinker-vs-Social Drinker
5.393800E-01
Weekly Drinker-vs-Occasional Drinker
6.909800E-01
Weekly Drinker-vs-Social Drinker
7.899000E-01
Occasional Drinker-vs-Social Drinker
2.845400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.726600E-01
Normal-vs-Grade 2
9.720400E-01
Normal-vs-Grade 3
9.886400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.867800E-02
Grade 1-vs-Grade 3
5.819600E-03
Grade 1-vs-Grade 4
8.726600E-01
Grade 2-vs-Grade 3
2.707600E-01
Grade 2-vs-Grade 4
9.720400E-01
Grade 3-vs-Grade 4
9.886400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.071400E-01
Normal-vs-NonDiabetic
4.179400E-01
Diabetic-vs-NonDiabetic
8.248000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.429800E-01
Normal-vs-NoPancreatitis
4.293800E-01
Pancreatitis-vs-NoPancreatitis
2.639000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.294600E-01
Normal-vs-N1
4.508800E-01
N0-vs-N1
6.787400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.131800E-01
Normal-vs-TP53-NonMutant
3.750200E-01
TP53-Mutant-vs-TP53-NonMutant
5.511800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
